MENU
ITRM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Iterum Therapeutics (ITRM) Ownership - Who owns Iterum Therapeutics?
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
45.13M
P/E Ratio
N/A
Total Cash
24.13M
Projected Growth
N/A
Total Debt
45.53M
Revenue
N/A
Risk (Beta)
3.79
Dividend Yield
N/A
Total Cash/Share
0.70
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ITRM
Capitalization
45.1M
P/E Ratio
N/A
Risk (Beta)
3.79
Dividend Yield
N/A
Total Cash
24.1M
Total Cash/Share
0.70
Total Debt
45.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-4.08M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-1.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
315K
Current Ratio
1.41
Current Revenue Per Employee
770.83
Dividends Per Share - Security
N/A
EBITDA
-21.73M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-69.93
Shares Held By Institutions
77.4M
Shares Outstanding - Current
34.6M
Total Liabilities
48.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
-23.729
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
an operator, which engages in the healthcare industry focusing on biotechnology business
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com